logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Dendreon Priced To Go Out of Business

  +Follow August 23, 2013 4:12PM
Share:
Tickers Mentioned:

An analyst at Deutsche Bank downgraded Dendreon Corp. (DNDN) on Aug. 23, lowering the price target on the biotech company all the way to $1 a share. The bank noted that Dendreon has posted disappointing sales of their prostate cancer treatment drug Sipuleucel-T  (trade name Provenge) and is accumulating massive debt, and is in trouble of going under completely.

Duetsche's assessment of the Seattle, Wa.-based biotech was dire. In a note to investors, analyst Robyn Karnauskas wrote, “Per our calculations, even if there is drastic restructuring and significant cost cuts, spending may still outpace [revenue] growth in the near term. Consequentially, we believe that the terms of a debt refinancing may have a negative impact on equity holders.” The company downgraded Dendreon to “sell.” Deutsche had previously held a $6 price target for the stock.

Following Dendreon’s dismal second quarter earnings on Aug. 17, Wedbush Securities analyst David Nierengarten was even more pessimistic than Deutsche, and put his price target of the company at zero. That is, the only option for the troubled company is to file for bankruptcy.

Nierengarten said the company’s flagship product Provenge has always been doomed, as it is too expensive to produce and turn a profit, and thus Dendreon stands no chance of survival.

Dendreon was priced as high as $57.67 a share in April 2010 following the FDA approval of Provenge, and the stock hovered between $30 and $40 until Aug. 4, 2011. On that date the company abandoned its forecast for Provenge, and the stock fell 66 percent that day, and has continued plummeting since.

Dendreon dropped 9.72 percent on the poor analyst forecast to hit $2.88 a share, the lowest the stock has been in over four years.

(image courtesy of Flickr)

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for dndn
Nicholas Skiadas MD
27 Feb 15 04:19:30
CG needs a lesson from $DNDN. 1. $SRPT needs sales team=cheaper to partner with pharma. 2.stop listening to Edelman=short @matthewherper
PennyStocker
26 Feb 15 13:00:09
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
Dr. Zoidberg
26 Feb 15 12:41:26
$VRX touts Ph2 #Provenge data following $DNDN purchase http://t.co/6NmKJoBfW1
Trade Bait
26 Feb 15 08:20:45
$ziop just announce already and give me that $dndn zoom.
TradeTexasBig
26 Feb 15 04:27:58
biotech tickers that didn't make $rigl $dyax $adlr $dndn $sqnm A reminder for today ! Good morning
Penny Stock Secret
25 Feb 15 21:42:57
This Guy Turned $100 Into Over $10,000 In Just 30 Days!!! http://t.co/NovWYe2RAx ... $DNDN $NAII $VOXX
$Stocknewsalerts
25 Feb 15 16:31:23
$DNDN New SEC Document(s) for Dendreon Corporation From our Stock News Alerts App
Stockguy22
25 Feb 15 14:36:09
hi Nate @InvestorsLive someone sent me link to that old $DNDN $117k+ trade - thought twitpic shutdown but still there http://t.co/YknP8r2FgQ
Bob Holtsman
25 Feb 15 09:02:13
RT @psuvafan007: $KITE & CAR-T manufacturing http://t.co/JKCLh8xbi4 $JUNO $NVS $QURE $DNDN More evidence of locking up GMP compliant biolog…
PennyStocker
25 Feb 15 07:49:49
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
Влад
25 Feb 15 04:23:05
RT @dougheuringaria: IMPROVEMENT IN MANUFACTURING PROCESS IS A KEY FOCUS FOR ALL CAR-T COMPANIES $DNDN $KITE $JUNO http://t.co/q5H1ylhAdL
Joe
24 Feb 15 18:46:04
@BarbarianCap @LongShortTrader I'll bet it's $vrx. Bought garbage $dndn/roll up co/may lose $slxp bid...gonna tank 1 day. When music stops.
Daily Contracts
24 Feb 15 14:48:15
$DNDN News: And Assignment Of Certain Executory... http://t.co/cUzOncxIZH #dendreon #delaware
PennyStocker
24 Feb 15 13:06:41
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
PennyStocker
24 Feb 15 11:14:32
Wow the last pick from http://t.co/p3LC54ps4x popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
BioInvestor
24 Feb 15 07:34:12
$OXGN promising Pipeline !! $TKMR $gene $rosg http://t.co/FLtlpVpCaX $CLDX $ARIA $DNDN $ACAD $INCY $PFE $BMRN $ISIS $REG $INO
PennyStocker
24 Feb 15 06:31:46
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
Walter White
24 Feb 15 06:00:04
@Dougallan1 $DNDN failed because of @Alpine_Mitch killing the company with debt after cashing out his money. Drug was solid.
Douglas Allan
24 Feb 15 05:54:25
Yellen might repeat #biotech overvalued. Many future $DNDN's & $GILD's. Clinical trial results to determine winners/losers not #FED
TalkMarkets
24 Feb 15 05:45:05
Valeant Edges Up 15% After Announcing That It Will Acquire Salix $VRX $SLXP $DNDN $AGN $ACT http://t.co/0KaXtX8Olh
TalkMarkets Recap
23 Feb 15 23:44:27
Valeant Edges Up 15% After Announcing That It Will Acquire Salix $VRX $SLXP $DNDN $AGN $ACT http://t.co/Q8Z5yXWNDS
TalkMarkets
23 Feb 15 17:05:50
Valeant Edges Up 15% After Announcing That It Will Acquire Salix $VRX $SLXP $DNDN $AGN $ACT http://t.co/0KaXtX8Olh
Analyst Ratings
23 Feb 15 16:42:48
Want the latest analyst ratings on $METR $STL $WINN $DNDN $TEG? Get Them Delivered to Your Inbox http://t.co/nSJuDsYidj
PennyStocker
23 Feb 15 12:01:03
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
$Stocknewsalerts
23 Feb 15 08:01:43
$DNDN New SEC Document(s) for Dendreon Corporation From our Stock News Alerts App
PennyStocker
23 Feb 15 05:44:29
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
Michael Torres, PhD
23 Feb 15 05:12:43
RT @zbiotech: $VRX gets a new bag 'o tricks via $SLXP and $DNDN...inventories, synergies, margins, oh my
zach
23 Feb 15 05:09:42
$VRX gets a new bag 'o tricks via $SLXP and $DNDN...inventories, synergies, margins, oh my
A.J. Rotunno
23 Feb 15 05:07:34
RT @zbiotech: $VRX sees $DNDN synergies of 130M+ (incl mfg) w/GM expectations of 65% by YE'15...longer term to reach ~80%
zach
23 Feb 15 04:28:03
$VRX sees $DNDN synergies of 130M+ (incl mfg) w/GM expectations of 65% by YE'15...longer term to reach ~80%
Clark Joseph Kent
22 Feb 15 09:46:50
Valeant to buy Salix for $10.1B ($158/share) $VRX $SLXP $ENDP $SHPG $DNDN http://t.co/BsuOsmmrmQ
Tim Ayers
22 Feb 15 06:45:04
Last week $DNDN, this week $SLXP, would hate to be the integration team, Valeant nears deal to buy Salix, http://t.co/iKHOqvcPJt via @WSJ
PennyStocker
21 Feb 15 18:26:51
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
PennyStocker
21 Feb 15 14:03:13
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
Daily Contracts
21 Feb 15 06:00:09
$DNDN News: Second Amended And Restated Acquisition... http://t.co/ZO8baozv2V #dendreon
fezziwig2008
21 Feb 15 04:49:34
@PDRennert Lehman Bros went OB doing so with toxic mortgages - no therapy is immune to further innovation $DNDN was a toxic mortgage stream
Nathan Michaud
20 Feb 15 21:04:09
I speak to @stockguy22 maybe half dozen times a year on twitter but that $DNDN $100k PnL was a eye opener way back when
MAISA
20 Feb 15 17:18:27
$DNDN had sales of $283.7M in 2013 - when Provenge was approved in 2010, #WallStreetAnalysts projected the treatment could generate $4.3B
MAISA
20 Feb 15 17:17:18
$DNDN filed for bankruptcy in November after sales of the prostate cancer drug, Provenge, failed to meet expectations $VRX
MAISA
20 Feb 15 17:16:48
$DNDN U.S. Bankruptcy Judge Laurie Selber Silverstein would sign an order approving the expanded sale after some changes are made $VRX
MAISA
20 Feb 15 17:16:08
$DNDN A judge will let $DNDN, to sell most of its assets to an affiliate of Valeant Pharmaceuticals $VRX for $445M in cash and some stock
Conf Call Tran
20 Feb 15 16:40:04
Current report, items 1.01 and 9.01 $DNDN http://t.co/5YavdeeqAY
FinSentS NASDAQ
20 Feb 15 15:49:30
$DNDN:US Valeant Approved to Buy Dendreon Assets for $495 Million #DENDREON CORP http://t.co/V2cFlnhyTU #NASDAQ
$Stocknewsalerts
20 Feb 15 12:31:15
$DNDN New SEC Document(s) for Dendreon Corporation From our Stock News Alerts App
major events
20 Feb 15 12:05:19
Valeant Approved to Buy Dendreon Assets for $495 Million #wlst $DNDN #headlines http://t.co/hZb2X67Q3Z
Market Newswire
20 Feb 15 12:00:58
Valeant Approved to Buy Dendreon Assets for $495 Million - http://t.co/Z0wh8CRgzT $DNDN #markets #wallstreet #headlines
ProTradersNews
20 Feb 15 11:22:02
$DNDN: Dendreon's Enhanced $445 Million Sale to Valeant Approved: http://t.co/Lv3ho2P8mz
PennyStocker
20 Feb 15 08:34:42
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
$Stocknewsalerts
20 Feb 15 04:16:44
$DNDN New SEC Document(s) for Dendreon Corporation From our Stock News Alerts App
				
				
  +Follow August 23, 2013 4:12PM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.